Skip to main content

Evaluation of urinary cfDNA workflows for the molecular profiling of malignant disease.

Eberhard A, Moser T, Ziegler L, Vlachos G, Loibner M, Bauernhofer T, Balic M, Gerger A, Dandachi N, Beichler C, Glawitsch L, Moser M, Graf R, Abuja PM, Schmitz M, Krenz T, Voss T, Mancarella D, Heitzer E

Publication: iScience (2025) • Vol 28 • Page 113632PMID: 41142998View on PubMed

Purpose

This paper compared the stability of cell-free DNA (cfDNA) in unpreserved urine and urine preserved with PAXgene or Streck urine preservative during 4 days of room temperature storage. The authors then compared the detection of mutations in breast cancer, prostate cancer and colorectal cancer in patient plasma with that of case-matched urine that was stored for 0 or 3 days unpreserved or preserved with PAXgene or Streck preservatives. Mutations were detected using different platforms for each cancer type investigated.

Conclusion

Urine cfDNA levels were higher in specimens from women than men (P<0.001), but intra-individual variability was also higher in specimens from women than men. Urine cfDNA levels were more variable when quantified by Qubit than by PCR-based methods.  When unpreserved urine was stored for 3 h, DNA yield and DNA fragmentation increased, indicating the release of cellular DNA and degradation of cfDNA. In contrast, cfDNA levels were not affected by when urine in PAXgene or Streck tubes were stored for up to 96 h at room temperature.  Consequently, cfDNA levels were lower in unpreserved urine than PAXgene-preserved urine at all timepoints (P<0.001 for all), but were comparable in Streck- and PAXgene-preserved urine. Shallow whole genome sequencing showed that urine cfDNA ranged from 50-500 bp with a 10 bp periodicity, but there was an increase in the number of fragments <150 bp in unpreserved urine specimens. Mutations and copy number variants were detected in preserved urine from cancer patients, but detection was generally at a lower variant allele frequency than in plasma. When urine was not preserved, there was a higher rate of sequencing library failure and a decrease in the detection of mutations using digital PCR.

Studies (2)

Purpose

This study compared the stability of cell-free DNA (cfDNA) in unpreserved urine and urine preserved with PAXgene or Streck urine preservative during 4 days of room temperature storage. Second-morning urine was collected from healthy volunteers (19 women and 20 men) into BD Vacutainer Urine Collection Cups. Urine from 10 women and 10 men was split into PAXgene Urine Liquid Biopsy Tubes and plain tubes, and urine from the remaining 9 women and 10 men was divided between PAXgene Urine Liquid Biopsy Tubes and tubes containing a 1:5 ratio of Streck urine preservative. Urine was then stored for 0, 3, 6, 24, 48 and 96 h at room temperature, centrifuged at 1900 g for 15 min followed by 1900 g for 10 min (PAXgene and unpreserved urine) or 2,700g for 10 min (Streck urine), and the supernatants were frozen at -80°C. DNA was extracted with the QIAsymphony DSP Circulating DNA Kit on a QIAsymphony SP instrument. DNA was quantified using the Qubit dsDNA High Sensitivity Kit, real-time PCR amplification of a 66 bp fragment of the 18S rRNA gene, the digital PCR-based TaqMan RNase P assay and the Quantiplex Pro multiplex assay.

Summary of Findings

Urine cfDNA levels were higher in urine specimens from women than men (P<0.001), but intra-individual variability was also higher in specimens from women than men. Urine cfDNA levels were more variable when quantified by Qubit than PCR-based methods.  When unpreserved urine was stored for 3 h, DNA yield and DNA fragmentation increased, indicating the release of cellular DNA and degradation of cfDNA. In contrast, cfDNA levels were not affected when PAXgene or Streck tubes were stored for up to 96 h at room temperature.  Consequently, cfDNA levels in unpreserved urine were lower than PAXgene-preserved urine at all timepoints (P<0.001 for all), but were comparable in Streck- and PAXgene-preserved urine. Shallow whole genome sequencing showed that urine cfDNA ranged from 50-500 bp with a 10 bp periodicity, but there was an increase in the number of fragments <150 bp in unpreserved urine.

  • Biospecimens

    FluidUrine
  • Preservation Types

    Streck/BCTPAXgeneNone (Fresh)
  • Diagnoses

    Normal
  • Platforms

    DNAAutomated electrophoresis/Bioanalyzer
    DNADigital PCR
    DNAFluorometry
    DNAReal-time qPCR
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    PreaquisitionPatient gender
    Female
    Male
    Biospecimen PreservationType of fixation/preservation
    None (fresh)
    PAXgene
    Streck cfDNA urine presevative
    StorageStorage duration
    0 h
    24 h
    3 h
    48 h
    6 h
    96 h
    Fluorometry SpecificTechnology platform
    Digital PCR based TaqMan RNase P assay
    Quantiplex Pro multiplex assay
    Qubit
    Real-time PCR of 18S rRNA gene